META climbed roughly 34.8% over the last 30 days, rising from about $549.90 to $741.245 per share. The rally was powered by strong early adoption of Muse, Meta's new personal AI agent, which surged to the top of Apple's App Store charts.

AMD shares climbed roughly 30% over the trailing 30 days, from a close near $473 to about $615, pushing the company's market value above $1 trillion for the first time. The rally was powered by surging AI-driven demand for data-center CPUs and GPUs, led by the EPYC server line and the Instinct MI400 and Helios accelerators.

Intel shares climbed roughly 35% over the 30-day period ending in late September 2026, rising from a closing price near $90 to about $121.78. The advance was fueled by renewed AI-server CPU demand, a reported SK Hynix manufacturing partnership, and a wave of Wall Street upgrades.

NIO's American depositary shares fell roughly 20.7% over the last 30 days, declining from a closing price of $4.63 on August 21 to $3.67 on September 21. The pullback extended a longer downtrend, with the stock down approximately 27% over the last quarter, from about $5.05 in late June.

Planet Labs PBC (PL) has fallen roughly 23% over the past 30 days, declining from a closing price of $22.29 on August 21, 2026, to $17.07 on September 21, 2026. The pullback extends a multi-month slide; measured from late June, when shares traded near $28–$29, the stock is down about 40%.

MaxLinear shares climbed roughly 29% over the trailing 30 days, rising from about $66.61 to $85.98, reflecting renewed momentum in AI-driven data center optical interconnects. The advance followed a sharp early-September dip toward the mid-$50s, meaning the stock staged a pronounced V-shaped recovery rather than a steady climb.

CAI shares advanced roughly 16.7% over the last 30 days, from about $26.27 to $30.65, extending a broader multi-month rally. The move reflects follow-through from record second-quarter 2026 results, including 45% year-over-year revenue growth and a raised full-year outlook.

The selected price target is $128 per share , roughly the top of the current Wall Street analyst price-target range. With shares recently trading near $117, reaching $128 would require a gain of roughly 9% from current levels.

BWET has surged roughly +96% over the last 30 days , rising from approximately $398 to around $780, as crude oil tanker freight futures hit historic highs. The move extends a multi-month uptrend : over the trailing three months, the fund is up roughly +272% from about $210.

The T-Rex 2X Long MSTR Daily Target ETF (MSTU) gained roughly 95% over the trailing 30 days, tracking a sharp rebound in Strategy (MSTR) shares. MSTU seeks 2x daily exposure to MSTR , so its advance reflects both MSTR's roughly 47% rise and the amplified effect of daily compounding during a sustained uptrend.

FBL is a leveraged single-stock exchange-traded fund (ETF) that seeks 2x (200%) of the daily price return of Meta Platforms (NASDAQ: META ) stock, before fees and expenses. The fund has gained roughly +77% over the trailing 30 days and about +59% over the last quarter, reflecting amplified exposure to a sharp rally in META shares.

DLLL advanced roughly 30% over the past 30 days, tracking a surge in its underlying single-stock exposure to Dell Technologies (DELL). The fund seeks 200% of the daily return of DELL common stock, magnifying both gains and losses through daily rebalancing.

BEX gained roughly 17% over the last 30 days, reflecting a rebound in its single underlying holding, Bloom Energy (BE) . Over the trailing three months, BEX fell about 43% even though BE declined only a high-single-digit percentage, highlighting the volatility decay of a daily-reset leveraged fund.

TLX fell -9.85% to about $11.35 during Monday's regular session, down from a prior close of $12.59. The drop followed Telix's $1.65 billion upfront merger agreement with privately held German radioisotope producer ITM Isotope Technologies Munich.

KPLT fell about -10.53% during regular trading Monday, sliding from a $9.50 prior close to roughly $8.50. The move reverses Friday's +3.37% gain and a heavy-volume spike, after a ~+60% one-month surge following its August all-stock merger with The Aaron's Company and CCF Holdings.

PBLS fell -11.84% to $36.79 during regular trading Monday, down from Friday's $41.73 close. The drop came amid a broad biotech and pharmaceutical selloff, with PBLS among the session's biggest sector losers.

BRVE is down -14.32% to $25.02 during Monday's regular session, off Friday's $29.20 close, on heavy volume (~1.0M shares vs ~464K average). The slide extends a post-earnings selloff after Sept 8 Q2 results showed a far wider loss (diluted EPS -$2.51 vs -$0.25 consensus) with zero revenue.

APMD fell -12.66% during regular trading, retreating to roughly $25.33 from Friday's $29.00 close. The decline follows Friday's +3.17% surge on ~3.1M shares—well above its ~531K average—leaving the newly public biotech prone to profit-taking.

EMAT is trading down -16.42% to roughly $3.36 during regular market hours, sliding from Friday's close of $4.02. The decline follows a Yorkville financing deal of up to $30.93M in convertible debentures, including an immediate $22M tranche.

Magnachip Semiconductor (MX) climbed +16.36% to roughly $3.20 during regular trading, extending gains that began premarket. The move was driven by Navitas Semiconductor's announcement of a $5 million strategic equity investment, buying ~1.46 million Magnachip shares at $3.42 each.